Cellectis (CLLS) Gross Profit Growth (5y) (2020 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -14.10% |
| Sep 30, 2023 | -49.94% |
| Jun 30, 2023 | -51.30% |
| Mar 31, 2023 | -15.28% |
| Dec 31, 2022 | -62.81% |
| Sep 30, 2022 | -15.26% |
| Jun 30, 2022 | 36.17% |
| Mar 31, 2022 | -26.90% |
| Dec 31, 2021 | -14.98% |
| Sep 30, 2021 | -15.80% |
| Jun 30, 2021 | -29.71% |
| Mar 31, 2021 | 19.31% |
| Dec 31, 2020 | -16.48% |
| Sep 30, 2020 | -17.11% |
| Jun 30, 2020 | -18.96% |
| Mar 31, 2020 | 38.17% |